Luuk J Rijzewijk
Overview
Explore the profile of Luuk J Rijzewijk including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
1076
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
de Gonzalo-Calvo D, Kenneweg F, Bang C, Toro R, van der Meer R, Rijzewijk L, et al.
J Am Coll Cardiol
. 2016 Dec;
68(25):2914-2916.
PMID: 28007154
No abstract available.
2.
Chen W, Greulich S, van der Meer R, Rijzewijk L, Lamb H, de Roos A, et al.
Cardiovasc Diabetol
. 2013 Oct;
12:150.
PMID: 24134550
Background: Activin A released from epicardial adipose tissue has been linked to contractile dysfunction and insulin resistance in cardiomyocytes. This study investigated the role of activin A in clinical diabetic...
3.
Greulich S, Chen W, Maxhera B, Rijzewijk L, van der Meer R, Jonker J, et al.
PLoS One
. 2013 Apr;
8(3):e59697.
PMID: 23555749
Context: Adipokines are linked to the development of cardiovascular dysfunction in type 2 diabetes (DM2). In DM2-patients, circulating levels of omentin-1, an adipokine preferentially expressed in epicardial adipose tissue, are...
4.
Widya R, van der Meer R, Smit J, Rijzewijk L, Diamant M, Bax J, et al.
Diabetes Care
. 2012 Nov;
36(2):457-62.
PMID: 23139371
Objective: To compare magnetic resonance imaging-derived right ventricular (RV) dimensions and function between men with type 2 diabetes and healthy subjects, and to relate these parameters to left ventricular (LV)...
5.
Chen W, Rijzewijk L, van der Meer R, Heymans M, van Duinkerken E, Lubberink M, et al.
Cardiovasc Diabetol
. 2011 Jul;
10:67.
PMID: 21771299
Background: Osteoprotegerin (OPG), a soluble member of the tumor necrosis factor receptor superfamily, is linked to cardiovascular disease. Negative associations exist between circulating OPG and cardiac function. The adipocytokine adiponectin...
6.
Ng A, Delgado V, Bertini M, van der Meer R, Rijzewijk L, Ewe S, et al.
Circulation
. 2010 Dec;
122(24):2538-44.
PMID: 21126971
Background: Magnetic resonance spectroscopy can quantify myocardial triglyceride content in type 2 diabetic patients. Its relation to alterations in left (LV) and right (RV) ventricular myocardial functions is unknown. Methods...
7.
Rijzewijk L, van der Meer R, Lubberink M, Lamb H, Romijn J, de Roos A, et al.
Diabetes
. 2010 Aug;
59(11):2747-54.
PMID: 20693345
Objective: Hepatic steatosis is common in type 2 diabetes. It is causally linked to the features of the metabolic syndrome, liver cirrhosis, and cardiovascular disease. Experimental data have indicated that...
8.
Rijzewijk L, Jonker J, van der Meer R, Lubberink M, de Jong H, Romijn J, et al.
J Am Coll Cardiol
. 2010 Jul;
56(3):225-33.
PMID: 20620743
Objectives: The purpose of this study was to investigate the relationship between hepatic triglyceride content and both myocardial function and metabolism in type 2 diabetes mellitus (T2DM). Background: Heart disease...
9.
Jonker J, Wang Y, de Haan W, Diamant M, Rijzewijk L, van der Meer R, et al.
Diabetes Care
. 2010 Feb;
33(7):1625-8.
PMID: 20150294
Objective: Thiazolidinediones reduce hepatic steatosis and increase HDL cholesterol levels. In mice with human-like lipoprotein metabolism (APOE*3-Leiden.CETP transgenic mice), a decrease in hepatic triglyceride content is associated with a decrease...
10.
Ng A, Delgado V, Bertini M, van der Meer R, Rijzewijk L, Shanks M, et al.
Am J Cardiol
. 2009 Nov;
104(10):1398-401.
PMID: 19892057
Regional left ventricular (LV) myocardial functional changes in early diabetic cardiomyopathy have not been well documented. LV multidirectional strain and strain rate analyses by 2-dimensional speckle tracking were used to...